Press Releases

Netherlands Denounces Houthi Attack on Dutch Vessel

(MENAFN) The Netherlands has voiced strong disapproval of a recent assault carried out by Houthi forces on a Dutch cargo vessel operating in the Gulf of Aden. On Wednesday, caretaker Foreign Minister David van Weel expressed the country's position...

Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20

EINDHOVEN, the Netherlands, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...

Fortified Dairy Products Market Size to Worth USD 222.82 Billion by 2034, Driven by Health-Conscious Consumers and Plant-Based Options

Ottawa, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The global fortified dairy products market size stood at USD 124.42 billion in 2024 and is expected to rise from USD 131.89 billion in 2025 to reach nearly USD 222.82 billion by 2034, expanding at a CAGR...

LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positive Effects on Cognition and Negative Symptoms

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that three posters featuring new and previously reported analyses from its Phase 2 NOVA1 clinical trial of...

PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand

TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules...

[Latest] Global Virtual Clinical Trials Market Size/Share Worth USD 15.8 Billion by 2034 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Virtual Clinical Trials Market Size, Trends and Insights By Study Design (Interventional, Observational, Expanded Access), By...

AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage

Utrecht, The Netherlands, October 2, 2025 – AM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac surgery-associated...

UCLA Health Chaplain Keith Wakefield Announces Upcoming Release of Stay with Me, I Want to Be Alone

A powerful memoir exploring presence, meaning, and humanity in life’s most difficult moments LOS ANGELES, CA, UNITED STATES, October 1, 2025 /⁨EINPresswire.com⁩/ -- Keith Wakefield, ACPE Certified Educator and Manager of CPE Programs at UCLA...

Global Hospital Capacity Management Solutions Market Size/Share Worth USD 9.3 Billion by 2034 at a 10.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hospital Capacity Management Solutions Market Size, Trends and Insights By Solution Type (Capacity Management Software, Capacity...

aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025

Clinical benefit for efzofitimod across multiple disease-related health outcomes reported. Improvement in Fatigue Assessment Scale Total Score at week 48 observed in the 5.0 mg/kg efzofitimod treatment group vs placebo (p=0.0226). Improvement in...

Kynexis Announces First Patient Dosed in Phase 2 Clinical Trial of KYN-5356 for Cognitive Impairment Associated With Schizophrenia

Based on previously reported positive Phase 1 results, Kynexis is advancing KYN-5356, a first-in-class KAT-II inhibitor, into a Phase 2 clinical trial in patients with cognitive impairment associated with schizophrenia Phase 2 trial seeks to...

AI in Healthcare Market (2025-2032) | $347.28B Growth Driven by Diagnostics, Analytics & Robotics

Artificial intelligence (AI), or intelligence demonstrated by machines, is heavily influencing many industries. WILMINGTON, DE, UNITED STATES, September 30, 2025 /⁨EINPresswire.com⁩/ -- Global Artificial Intelligence in Healthcare Market Overview...

Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress

– Data show verekitug prevents TSLP binding to the TSLP receptor by occupying ligand binding sites – – Additionally, findings show that verekitug outcompetes TSLP in the presence of preformed heterodimeric receptor complexes – – Data support the...

ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®

Initial $100 million term loan to propel market share growth in the U.S. SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients...

UNGA80 High-Level Side Event: 'No Health Without Mental Health: A shared commitment'

Leaders and experts from around the world gathered at the UN General Assembly high-level side event “No Health Without Mental Health: A shared commitment." NEW YORK, NY, UNITED STATES, September 26, 2025 /⁨EINPresswire.com⁩/ -- Leaders and experts...

Philips joins Optum Healthcare’s network as a preferred provider in the USA

September 25, 2025 Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a...

[Latest] Global Digestive Health Products Market Size/Share Worth USD 124.4 Billion by 2034 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Digestive Health Products Market Size, Trends and Insights By Ingredient (Probiotics, Prebiotics, Enzymes, Others), By Form...

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease

~ Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by cUHDRS compared to a propensity score-matched external control ~ ~ High-dose AMT-130 also demonstrated...

NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum

NAARDEN, The Netherlands and MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...

InnerBuddies Launches Next-Generation Gut Health Operating System Dashboard for Partners Worldwide

InnerBuddies launches new version of its white-label Gut Health Operating System. The new platform sets a new global standard for gut microbiome test solutions. VENLO, LIMBURG, NETHERLANDS, September 23, 2025 /⁨EINPresswire.com⁩/ -- InnerBuddies...